Thanks to new advancements in science, the emerging health benefits of HMOs can be leveraged to support consumers throughout life. Offering the widest portfolio of commercially available HMOs to more than 165 countries worldwide, DSM’s science-backed GlyCare™ HMOs have an extensive history in the market. DSM’s broad portfolio of high-quality products, customized solutions and expert services – supported by our fully integrated and dedicated HMO production site – make us your end-to-end partner in bringing purpose-led HMO innovation to the early life nutrition and dietary supplement markets.
Clinical data in infants indicate that HMOs support the development of desired microbiota by serving as a food source for the good bacteria in the intestine. Find out how DSM’s HMOs platform can support you in developing purpose-led products for healthier, happier childhoods.
With consumer interest in gut health increasing threefold in the last five years,1 discover how DSM’s HMO portfolio can help you expand your dietary supplements offering with science-backed digestive health solutions.
Your end-to-end partner for HMO innovation
DSM is spearheading innovation in the field of oligosaccharides with the widest range of commercially available HMOs. As a reliable end-to-end, innovative and purpose-led provider, DSM offers a broad portfolio of science-backed products and customized solutions powered by expert services uniquely aimed at supporting your entire product life cycle, from concept to consumer. This takes more than ingredients, it takes a partner.